Rare Disease Diagnostics Market Report 2026
Download Free Sample Buy Now
Rare Disease Diagnostics Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Rare Disease Diagnostics Market Report 2026

Global Outlook – By Test Type (Genetic Test, General Lab Test, Imaging Test), By Technology (Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarrays), By Sample Type (Deoxyribonucleic Acid (DNA) Sample, Buccal Swab Sample, Blood, Saliva), By Disease Type (Gastroenterology Disease, Endocrine And Metabolism Disorders Disease, Hematology And Oncology Disease, Dermatology Disease, Cardiovascular Disorders, Neurology Disease), By End User (Hospital Laboratories, Diagnostics Laboratories, Genetic Testing Laboratories, Cancer Research Laboratories) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Rare Disease Diagnostics Market Overview

• Rare Disease Diagnostics market size has reached to $38.14 billion in 2025

• Expected to grow to $62.18 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%

• Growth Driver: A Surge In Rare Disease Incidence And Diagnostics

• Market Trend: Technological Advancements Reshaping Diagnostics

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rare Disease Diagnostics Market?

Rare disease diagnostics refers to the process of identifying and diagnosing medical conditions that are considered rare or uncommon. These diagnostics are used for early detection and diagnosis, as well as the selection of targeted and personalized treatment plans for uncommon disorders.

The main tests included in rare disease diagnostics are genetic tests, general lab tests, and imaging tests. A genetic test refers to a laboratory procedure that examines the chromosomes, genes, or gene expression in human cells or tissue. The various technologies are included, such as capillary sequencing, whole genome sequencing, whole exome sequencing, and microarrays that use different samples, such as deoxyribonucleic acid (DNA) samples, buccal swab samples, blood, and saliva, for various diseases diagnosis, including gastroenterology disease, endocrine and metabolism disorders disease, hematology and oncology disease, dermatology disease, cardiovascular disorders, and neurology disease. These are used by several end-users, such as hospital laboratories, diagnostics laboratories, genetic testing laboratories, and cancer research laboratories.

Rare Disease Diagnostics Market Global Report 2026 Market Report bar graph

What Is The Rare Disease Diagnostics Market Size and Share 2026?

The rare disease diagnostics market size has grown strongly in recent years. It will grow from $38.14 billion in 2025 to $41.91 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to expansion of genetic testing availability, rising awareness of rare diseases among clinicians, increasing use of molecular diagnostics, growth of specialized diagnostic laboratories, improved access to advanced imaging technologies.

What Is The Rare Disease Diagnostics Market Growth Forecast?

The rare disease diagnostics market size is expected to see rapid growth in the next few years. It will grow to $62.18 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to expansion of personalized medicine adoption, rising investments in genomics research, growing demand for early-stage rare disease detection, increasing integration of ai-driven diagnostic tools, expansion of rare disease screening programs. Major trends in the forecast period include increasing adoption of next-generation sequencing diagnostics, rising use of multi-gene panel testing, growing integration of advanced imaging in rare disease diagnosis, expansion of centralized rare disease testing centers, enhanced focus on early and accurate diagnosis.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Rare Disease Diagnostics Market Segmentation

1) By Test Type: Genetic Test, General Lab Test, Imaging Test

2) By Technology: Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarrays

3) By Sample Type: Deoxyribonucleic Acid (DNA) Sample, Buccal Swab Sample, Blood, Saliva

4) By Disease Type: Gastroenterology Disease, Endocrine And Metabolism Disorders Disease, Hematology And Oncology Disease, Dermatology Disease, Cardiovascular Disorders, Neurology Disease

5) By End User: Hospital Laboratories, Diagnostics Laboratories, Genetic Testing Laboratories, Cancer Research Laboratories

Subsegments:

1) By Genetic Test: Whole Genome Sequencing, Targeted Gene Panels, Exome Sequencing, Carrier Testing

2) By General Lab Test: Blood Tests, Biochemical Assays, Urine Tests, Cytogenetic Tests

3) By Imaging Test: MRI (Magnetic Resonance Imaging), CT (Computed Tomography) Scans, Ultrasound, X-Rays

What Is The Driver Of The Rare Disease Diagnostics Market?

The increasing incidence of rare diseases is expected to propel the growth of the rare disease diagnostics market going forward. Rare diseases are health conditions that affect a small proportion of the population compared to more common diseases, often requiring specialized diagnostic tools for early and accurate detection. Rare disease diagnostics help improve disease management, enable identification of potential therapeutics, and reduce unnecessary or harmful treatments, thereby supporting more effective patient care. For instance, in March 2025, according to Kidney Research UK, an UK-based kidney disease charity, currently, the rare kidney disease landscape includes over 150 distinct conditions, affecting an estimated 70 per 100,000 people, predominantly arising from genetic alterations. Therefore, the surge in rare disease incidence is driving the growth of the rare disease diagnostics industry.

Key Players In The Global Rare Disease Diagnostics Market

Major companies operating in the rare disease diagnostics market are Thermo Fisher Scientific Inc., Roche Diagnostics, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Sanofi Genzyme, Illumina Inc., Bio Rad Laboratories Inc., Qiagen NV, OPKO Health Inc., Natera Inc., Invitae Corporation, BGI Genomics Co. Ltd., 23andMe Holding Co., Ambry Genetics Corporation, Centogene N.V., GENEWIZ Inc., Blueprint Genetics Inc., Oxford Gene Technology Limited, Strand Life Sciences Pvt. Ltd., RareCyte Inc., Sophia Genetics SA, Foundation Medicine Inc.

Global Rare Disease Diagnostics Market Trends and Insights

Major companies operating in the rare disease diagnostics market are focusing on developing advanced solutions, such as high-sensitivity whole genome sequencing (WGS) platforms, to improve diagnostic precision, expand variant detection, and accelerate the identification of complex rare disorders. High-sensitivity WGS platforms enable comprehensive analysis of nearly all disease-causing genetic variants in a single test, supporting earlier and more accurate diagnoses. For instance, in April 2023, Centogene GmbH, a Germany-based rare disease company, launched CentoGenome, an enhanced next-generation sequencing (NGS)-based whole genome sequencing solution designed for the diagnosis of rare and neurodegenerative diseases. The platform delivers broad variant coverage, including Copy Number Variations (CNVs) associated with spinal muscular atrophy (SMA) and complex pathogenic variants linked to Gaucher disease (GD) and GBA1-related Parkinson’s disease. Additionally, CentoGenome incorporates PCR-free technology to reduce sequencing bias in difficult genomic regions, enabling higher-quality data and deeper insight into coding, regulatory, and intronic areas to support more accurate clinical interpretation.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Rare Disease Diagnostics Market?

In August 2024, Labcorp, a US-based diagnostics and laboratory services company, acquired select assets from Invitae for an undisclosed amount. Through this acquisition, Labcorp seeks to strengthen its position in the rare disease diagnostics market by integrating Invitae’s advanced genetic testing assets and expanding access to high-complexity genomic diagnostics for underserved patient groups. Invitae is a US-based genetic testing and diagnostics company specializing in rare disease testing.

Regional Outlook

North America was the largest region in the rare disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rare Disease Diagnostics Market?

The rare disease diagnostics market consists of revenues earned by entities by providing services such as clinical evaluation, parallel sequencing, targeted sequencing, laboratory testing, and specialist consultation. The market value includes the value of related goods sold by the service provider or included within the service offering. The rare disease diagnostics market also includes sales of vision evaluation instruments, blood pressure cuffs, cardiac monitors, and advanced imaging equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Rare Disease Diagnostics Market Report 2026?

The rare disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rare disease diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Rare Disease Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $41.91 billion
Revenue Forecast In 2035 $62.18 billion
Growth Rate CAGR of 9.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Test Type, Technology, Sample Type, Disease Type, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Thermo Fisher Scientific Inc., Roche Diagnostics, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Sanofi Genzyme, Illumina Inc., Bio Rad Laboratories Inc., Qiagen NV, OPKO Health Inc., Natera Inc., Invitae Corporation, BGI Genomics Co. Ltd., 23andMe Holding Co., Ambry Genetics Corporation, Centogene N.V., GENEWIZ Inc., Blueprint Genetics Inc., Oxford Gene Technology Limited, Strand Life Sciences Pvt. Ltd., RareCyte Inc., Sophia Genetics SA, Foundation Medicine Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Rare Disease Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Rare Disease Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Rare Disease Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Rare Disease Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Next-Generation Sequencing Diagnostics

4.2.2 Rising Use Of Multi-Gene Panel Testing

4.2.3 Growing Integration Of Advanced Imaging In Rare Disease Diagnosis

4.2.4 Expansion Of Centralized Rare Disease Testing Centers

4.2.5 Enhanced Focus On Early And Accurate Diagnosis

5. Rare Disease Diagnostics Market Analysis Of End Use Industries

5.1 Hospital Laboratories

5.2 Diagnostic Laboratories

5.3 Genetic Testing Laboratories

5.4 Research Institutions

5.5 Specialty Clinics

6. Rare Disease Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rare Disease Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Rare Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Rare Disease Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Rare Disease Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Rare Disease Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rare Disease Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rare Disease Diagnostics Market Segmentation

9.1. Global Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetic Test, General Lab Test, Imaging Test

9.2. Global Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarrays

9.3. Global Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Deoxyribonucleic Acid (DNA) Sample, Buccal Swab Sample, Blood, Saliva

9.4. Global Rare Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gastroenterology Disease, Endocrine And Metabolism Disorders Disease, Hematology And Oncology Disease, Dermatology Disease, Cardiovascular Disorders, Neurology Disease

9.5. Global Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Laboratories, Diagnostics Laboratories, Genetic Testing Laboratories, Cancer Research Laboratories

9.6. Global Rare Disease Diagnostics Market, Sub-Segmentation Of Genetic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Genome Sequencing, Targeted Gene Panels, Exome Sequencing, Carrier Testing

9.7. Global Rare Disease Diagnostics Market, Sub-Segmentation Of General Lab Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Blood Tests, Biochemical Assays, Urine Tests, Cytogenetic Tests

9.8. Global Rare Disease Diagnostics Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

MRI (Magnetic Resonance Imaging), CT (Computed Tomography) Scans, Ultrasound, X-Rays

10. Rare Disease Diagnostics Market Regional And Country Analysis

10.1. Global Rare Disease Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Rare Disease Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rare Disease Diagnostics Market

11.1. Asia-Pacific Rare Disease Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rare Disease Diagnostics Market

12.1. China Rare Disease Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rare Disease Diagnostics Market

13.1. India Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rare Disease Diagnostics Market

14.1. Japan Rare Disease Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rare Disease Diagnostics Market

15.1. Australia Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rare Disease Diagnostics Market

16.1. Indonesia Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rare Disease Diagnostics Market

17.1. South Korea Rare Disease Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rare Disease Diagnostics Market

18.1. Taiwan Rare Disease Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rare Disease Diagnostics Market

19.1. South East Asia Rare Disease Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rare Disease Diagnostics Market

20.1. Western Europe Rare Disease Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rare Disease Diagnostics Market

21.1. UK Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rare Disease Diagnostics Market

22.1. Germany Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rare Disease Diagnostics Market

23.1. France Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rare Disease Diagnostics Market

24.1. Italy Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rare Disease Diagnostics Market

25.1. Spain Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rare Disease Diagnostics Market

26.1. Eastern Europe Rare Disease Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rare Disease Diagnostics Market

27.1. Russia Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rare Disease Diagnostics Market

28.1. North America Rare Disease Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rare Disease Diagnostics Market

29.1. USA Rare Disease Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rare Disease Diagnostics Market

30.1. Canada Rare Disease Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rare Disease Diagnostics Market

31.1. South America Rare Disease Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rare Disease Diagnostics Market

32.1. Brazil Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rare Disease Diagnostics Market

33.1. Middle East Rare Disease Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rare Disease Diagnostics Market

34.1. Africa Rare Disease Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Rare Disease Diagnostics Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rare Disease Diagnostics Market Regulatory and Investment Landscape

36. Rare Disease Diagnostics Market Competitive Landscape And Company Profiles

36.1. Rare Disease Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Rare Disease Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Rare Disease Diagnostics Market Company Profiles

36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

37. Rare Disease Diagnostics Market Other Major And Innovative Companies

Agilent Technologies Inc., PerkinElmer Inc., Sanofi Genzyme, Illumina Inc., Bio Rad Laboratories Inc., Qiagen NV, OPKO Health Inc., Natera Inc., Invitae Corporation, BGI Genomics Co. Ltd., 23andMe Holding Co., Ambry Genetics Corporation, Centogene N.V., GENEWIZ Inc., Blueprint Genetics Inc

38. Global Rare Disease Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Rare Disease Diagnostics Market

40. Rare Disease Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Rare Disease Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Rare Disease Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Rare Disease Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Rare Disease Diagnostics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Rare Disease Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Rare Disease Diagnostics Market, Supply Chain Analysis
  • Table 4: Global Rare Disease Diagnostics Market, Major Raw Material Providers
  • Table 5: Global Rare Disease Diagnostics Market, Major Resource Providers
  • Table 6: Global Rare Disease Diagnostics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Rare Disease Diagnostics Market, Major Distributors And Channel Partners
  • Table 8: Global Rare Disease Diagnostics Market, Key Technologies & Future Trends
  • Table 9: Global Rare Disease Diagnostics Market, Major Trends
  • Table 10: Global Rare Disease Diagnostics Market, Major End Users
  • Table 11: Global Rare Disease Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Rare Disease Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Rare Disease Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Rare Disease Diagnostics Market - TAM, US$ Billion, 2025
  • Table 15: Global Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Rare Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Rare Disease Diagnostics Market, Sub-Segmentation Of Genetic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Rare Disease Diagnostics Market, Sub-Segmentation Of General Lab Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Rare Disease Diagnostics Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Rare Disease Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Rare Disease Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Rare Disease Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Rare Disease Diagnostics Market - Company Scoring Matrix
  • Table 99: Thermo Fisher Scientific Inc. Financial Performance
  • Table 100: Roche Diagnostics Financial Performance
  • Table 101: Laboratory Corporation of America Holdings Financial Performance
  • Table 102: Quest Diagnostics Incorporated Financial Performance
  • Table 103: Eurofins Scientific SE Financial Performance
  • Table 104: Global Rare Disease Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Rare Disease Diagnostics Market, Competitive Dashboard
  • Table 106: Global Rare Disease Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Rare Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030
  • Table 108: Global, Rare Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 109: Global, Rare Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Sample Type, 2025 – 2030

List Of Figures

    Figure 1: Global Rare Disease Diagnostics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Rare Disease Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Rare Disease Diagnostics Market, Supply Chain Analysis
  • Figure 4: Global Rare Disease Diagnostics Market, Major Raw Material Providers
  • Figure 5: Global Rare Disease Diagnostics Market, Major Resource Providers
  • Figure 6: Global Rare Disease Diagnostics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Rare Disease Diagnostics Market, Major Distributors And Channel Partners
  • Figure 8: Global Rare Disease Diagnostics Market, Key Technologies & Future Trends
  • Figure 9: Global Rare Disease Diagnostics Market, Major Trends
  • Figure 10: Global Rare Disease Diagnostics Market, Major End Users
  • Figure 11: Global Rare Disease Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Rare Disease Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Rare Disease Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Rare Disease Diagnostics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Rare Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Rare Disease Diagnostics Market, Sub-Segmentation Of Genetic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Rare Disease Diagnostics Market, Sub-Segmentation Of General Lab Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Rare Disease Diagnostics Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Rare Disease Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Rare Disease Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Rare Disease Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Rare Disease Diagnostics Market - Company Scoring Matrix
  • Figure 99: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 100: Roche Diagnostics Financial Performance
  • Figure 101: Laboratory Corporation of America Holdings Financial Performance
  • Figure 102: Quest Diagnostics Incorporated Financial Performance
  • Figure 103: Eurofins Scientific SE Financial Performance
  • Figure 104: Global Rare Disease Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Rare Disease Diagnostics Market, Competitive Dashboard
  • Figure 106: Global Rare Disease Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Rare Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030
  • Figure 108: Global, Rare Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 109: Global, Rare Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Sample Type, 2025 – 2030

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

Read More About Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Healthcare Third-Party Logistics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Healthcare Third-Party Logistics Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Rare Disease Diagnostics Market Report 2026 - Global Outlook – By Test Type (Genetic Test, General Lab Test, Imaging Test), By Technology (Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarray...

Rare Diseases Treatment Market Report 2026 - Global Outlook – By Drug Type (Originator Drugs (Patented Molecules), Generic Drugs), By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectable, Oral...

Clinical Diagnostics Market Report 2026 - Global Outlook – By Test (Lab Test, Imaging Test, Other Tests), By Product (Instruments, Reagents, Other Products ), By End User (Hospital Laboratory, Diagnostic Laboratory, Poin...

Rare Kidney Diseases Market Report 2026 - Global Outlook – By Target Indication (IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications...

Infectious Disease Diagnostics Testing Market Report 2026 - Global Outlook – By Type (Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test), By Application (Respiratory, Human Immunod...

Minimal Residual Disease Testing Market Report 2026 - Global Outlook – By Test Type (DNA - Based Test, RNA- Based Test, Immunological Test), By Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation...

Rare Neurological Disease Treatment Market Report 2026 - Global Outlook – By Drug Type (Biologics, Small Molecules), By Therapy (Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Disease-Modifying Neurological T...

Primary Care POC Diagnostics Market Report 2026 - Global Outlook – By Product (Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertil...

Frequently Asked Questions

The Rare Disease Diagnostics Market Report 2026 market was valued at $38.14 billion in 2025, increased to $41.91 billion in 2026, and is projected to reach $62.18 billion by 2030. request a sample here

The expected CAGR for the Rare Disease Diagnostics Market Report 2026 market during the forecast period 2025–2030 is 10.4%. request a sample here

Major growth driver of the market includes: A Surge In Rare Disease Incidence And Diagnostics in the Rare Disease Diagnostics Market Report 2026 market. For further insights on this market, request a sample here

The rare disease diagnostics market covered in this report is segmented –
1) By Test Type: Genetic Test, General Lab Test, Imaging Test
2) By Technology: Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarrays
3) By Sample Type: Deoxyribonucleic Acid (DNA) Sample, Buccal Swab Sample, Blood, Saliva
4) By Disease Type: Gastroenterology Disease, Endocrine And Metabolism Disorders Disease, Hematology And Oncology Disease, Dermatology Disease, Cardiovascular Disorders, Neurology Disease
5) By End User: Hospital Laboratories, Diagnostics Laboratories, Genetic Testing Laboratories, Cancer Research Laboratories Subsegments:
1) By Genetic Test: Whole Genome Sequencing, Targeted Gene Panels, Exome Sequencing, Carrier Testing
2) By General Lab Test: Blood Tests, Biochemical Assays, Urine Tests, Cytogenetic Tests
3) By Imaging Test: MRI (Magnetic Resonance Imaging), CT (Computed Tomography) Scans, Ultrasound, X-Rays request a sample here

Major trend in this market includes: Technological Advancements Reshaping Diagnostics For further insights on this market, request a sample here.

Major companies operating in the Rare Disease Diagnostics Market Report 2026 market are Major companies operating in the rare disease diagnostics market are Thermo Fisher Scientific Inc., Roche Diagnostics, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Sanofi Genzyme, Illumina Inc., Bio Rad Laboratories Inc., Qiagen NV, OPKO Health Inc., Natera Inc., Invitae Corporation, BGI Genomics Co. Ltd., 23andMe Holding Co., Ambry Genetics Corporation, Centogene N.V., GENEWIZ Inc., Blueprint Genetics Inc., Oxford Gene Technology Limited, Strand Life Sciences Pvt. Ltd., RareCyte Inc., Sophia Genetics SA, Foundation Medicine Inc. request a sample here.

North America was the largest region in the rare disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us